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Congenital primary aphakia (CPA) is a rare developmental disorder characterized by the absence of lens, the development
of which is normally induced during the 4th–5th wk of human embryogenesis. This original failure leads, in turn, to
complete aplasia of the anterior segment of the eye, which is the diagnostic histological criterion for CPA. So far, the
genetic basis for this human condition has remained unclear. Here, we present the analysis of a consanguineous family
with three siblings who had bilateral aphakia, microphthalmia, and complete agenesis of the ocular anterior segment.
We show that a null mutation in the FOXE3 gene segregates and, in the homozygous state, produces themutantphenotype
in this family. Therefore, this study identiﬁes—to our knowledge, for the ﬁrst time—a causative gene for CPA in humans.
Furthermore, it indicates a possible critical role for FOXE3 very early in the lens developmental program, perhaps earlier
than any role recognized elsewhere for this gene.
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Human aphakia is a rare congenital eye disorder in which
the lens is missing. It has been histologically subdivided
into primary and secondary forms, in accordance with the
severity of defects of the ocular tissues, whose develop-
ment requires the initial presence of a lens.1–4 Congenital
primary aphakia (CPA) results from an early developmen-
tal arrest, around the 4th–5th wk of gestation in humans,
that prevents the formation of any lens structure and leads
to severe secondary ocular defects, including a complete
aplasia of the anterior segment of the eye.4,5 In contrast,
in secondary aphakic eyes, lens induction has occurred,
and the lens vesicle has developed to some degree but
ﬁnally has progressively resorbed perinatally, leading,
therefore, to less-severe ocular defects. Few cases fulﬁll the
diagnostic criteria for CPA, and the most famous cases
histologically documented are those described by Man-
schot in 1963.4
So far, the underlying genetic causes of CPA have re-
mained obscure, but they undoubtedly are diverse, since
lens formation is dependent upon complex interactions
of numerous tissues deriving from surface ectoderm, neu-
ral ectoderm, and neural crest mesenchyme.6 However, a
major critical step in lens development is lens induction,
a multistep process that leads to the formation of the lens
placode.7 Many genes, including transcription factors, ho-
meobox genes, and signaling molecules, have been shown
to be involved in the control of each stage of lens devel-
opment. Although many of these components have been
well deﬁned and assembled in a provisional genetic path-
way, numerous questions remain concerning the temporal
and spatial coordination of their expression.7–12
Here, we have investigated a consanguineous family
with three children (IV.1, IV.3, and IV.4) whohave bilateral
aphakia in association with microphthalmia, complete
aplasia of the anterior segment of the eye, absence of iris,
and retinal dysplasia (ﬁgs. 1A, 2B, and 3A). All the family
members underwent a complete ophthalmologic exami-
nation that did not reveal ocular abnormalities in either
parent. In addition, all three affected children were re-
ferred to a pediatrician for an examination of associated
systemic anomalies, but none were detected, in particular
cerebral malformations or dysmorphic features (ﬁgs. 2C,
2D, 3C, and 3D). In this pedigree, there was no relevant
family history of ocular phenotype, and, since the parents
were consanguineous, this aphakia was most probably in-
herited in a recessive manner. The ﬁrst proband (IV.1) of
this kindred was born with bilateral aphakia and micro-
phthalmia and exhibited sclerocornea (data not shown).
This child died of infant sudden death syndrome at age
3 mo, for unknown reasons. Infectious and toxic causes
were ruled out, and chromosomal analysis showed a nor-
mal karyotype. An autopsy was performed and did not
reveal systemic malformation or neurological distortion,
and both eyes were removed for histological examination.
Histological examination of all sections of both eyes from
proband IV.1 indicated absence of lens or any residual lens
structures associated with a complete aplasia of the an-
terior segment, absence of iris, no ciliary body, no trabec-
ular meshwork or Schlemm’s canal, and dysplasia of the
retina (ﬁg. 4A–4C). All these severe anterior ocular defects
fulﬁll the diagnostic criteria of CPA, rather than that of
secondary congenital aphakia.4 The corneal epithelium
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Figure 1. Identiﬁcation of the FOXE3 nonsense mutation in the
family with CPA. A, Pedigree of the family with CPA, showing double
consanguinity and recessive inheritance pattern of the ocular phe-
notype. The affected individuals are identiﬁed by a blackened sym-
bol. Phenotypically normal carriers of the mutation are indicated
by a dot within the unblackened symbol. B, Sequence electro-
phoregrams of the novel C240X mutation. Left, Partial sequence
data from affected individual IV.3, indicating homozygosity (one
peak: the mutated nucleotide A) for the C240X mutation. Right,
Sequence data from his clinically asymptomatic mother (III.2),
showing heterozygosity (two peaks: the normal nucleotide C and
the mutated nucleotide A). Arrowheads indicate the position of
the mutated nucleotide. C, Comparison of human (Hs) and mouse
(Mm) FOXE3 C-terminal amino acid sequences. Red background,
Identical amino acids. Yellow background, Conservative substitu-
tions. The arrow points to the residue substituted in our patient.
appeared thinner and consisted of three cell layers, rather
than four or ﬁve. The corneal stroma contained cells with
ﬁbroblastic conﬁguration and was abnormally vasculari-
zed (ﬁg. 5A). The corneal endothelium was not observed
in either eye, and, after periodic acid schiff staining, nei-
ther Bowman’s layer nor Descemet’s membranes were de-
tected (ﬁg. 5A). Instead of a corneal endothelium at the
posterior surface of the corneal stroma, there was a mass
of a highly vascularized ﬁbromuscular tissue, which was
covered by a pigmented epithelium that occasionally
formed some rudimentary pseudofolds, evoking the as-
pect of ciliary processes (ﬁg. 5A and 5B). By immuno-
chemistry, this pigmented epithelium stained positively
for vimentin antibody, but it was unstained with desmin,
a-smooth muscle actin, and CK7/CK20 antibodies, for a
cytoskeletal proﬁle suggestive of a ciliary epithelium (ﬁg.
5C and 5D). The layer of smooth muscular cells at the
posterior face of the corneal stroma was of variable thick-
ness, and these cells were found to be positive for anti–
a-smooth muscle actin and antidesmin antibodies and
negative for antivimentin antibody (ﬁgs. 4B and 5D).
Immunohistochemical analysis with HMB45 antibody,
which marks melanocyte cells, was performed, and the
choroid and a small number of cells within the vascular
ﬁbromuscular tissue adherent to the posterior face of the
corneal stroma stained positive (ﬁg. 5E and 5F). In com-
parison with human fetal eyes at 7, 13.5, and 17.5 wk of
development, we found that ciliary muscle and choroid
were the only ocular structures positive for HMB45 anti-
body (data not shown). The retina appeared dysplastic,
with rosette-like structures suggesting that the absence of
lens most probably disturbed but did not prevent the in-
vagination of the optic vesicule (ﬁg. 4A and 4C).13 How-
ever, outside the rosettes, the retina showed an apparently
normal architecture, in which all neuronal nuclear layers
were recognizable, reinforcing the idea that retinogenesis
is relatively normal in the absence of lens.14 This obser-
vation also indicates that the lens is required for proper
optic cup morphogenesis, therefore supporting the view
that contact between the optic vesicle and the prelens
ectoderm, but not the lens per se, triggers the optic vesicle
to form a cup.14
In the same family, two other children were born with
bilateral aphakia, which was conﬁrmed by magnetic res-
onance imaging (MRI) (ﬁgs. 2C, 2D, 3C, and 3D). Oph-
thalmologic examination of proband IV.3 revealed asym-
metric microphthalmia, a right megalocornea, and nor-
mal intraocular pressure (IOP) (ﬁg. 2B). However, at the
age of 3 years, IOP progressed in the patient’s right eye,
which led to severe buphthalmos requiring trabeculec-
tomy. In contrast to her brother, proband IV.4 presented
at birth with symmetricmicrophthalmiawith aphakia and
sclerocornea, with an IOP of 10 mm Hg in both eyes (ﬁg.
3A and 3B). At the present time, these children, aged 10
and 9 years, are in good health and have no intellectual
or neurologic impairment. During the third and the fourth
pregnancies, prenatal ultrasonography and MRIs succes-
sively performed at 16, 19, and 28.5 wk of gestation re-
vealed absence of lens or capsular remnants in both eyes
for probands IV.3 and IV.4, indicating that either the lens
had never been formed or was resorbed very early during
embryogenesis (ﬁg. 2A). The probability that both lenses
had formed and were bilaterally resorbed completely and
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Figure 2. Clinical phenotypes of patient IV.3. A, MRI (T2-weighted image) sagittal section at 28.5 wk of gestation. The fetal eyeball
appears as a white sphere (arrow), and the lens, normally visible inside as a black and well-circumscribed sphere, is absent. B, Aspect
of eyes of proband IV.3 at the age of 1 mo, revealing bilateral microphthalmia with aphakia in the right eye and extreme microphthalmia
of the left eye, preventing correct examination. C and D, Axial and sagittal sections of cerebral MRI (T1-weighted images) at the age
of 4 years, showing absence of lens, asymmetric eyeballs, and normal appearance of brain structures.
symmetrically in both affected children is highly unlikely.
Furthermore, the complete aplasia of the anterior segment
of the eye, documented histologically in both aphakic eyes
of proband IV.1, argues in favor of an absence of lens
formation during embryogenesis.
Since the karyotypes of the three infants were normal
and the size of the family did not allow linkage analysis,
we attempted the strategy of the candidate gene to iden-
tify the genetic cause of this congenital malformation.
Therefore, on the basis of either animal models or spa-
tial and temporal pattern of expression, we studied several
genes, including PAX6,15 PITX3 and its promoter,16,17
SIX3,18 BMP7,19 SOX2,12 FOXC1,20 and FOXE321–24 (MIM
601094). After receiving informed consent from the fam-
ily, we analyzed the entire coding region and intron-exon
boundaries of these genes by bidirectional direct sequenc-
ing, and all these genes were excluded as being causative,
except for FOXE3. In both living affected children (IV.3
and IV.4), we identiﬁed a homozygous nucleotide trans-
version, CrA, at nucleotide position 720, according to the
sequence published by Semina et al.24 (GenBank accession
number AF275722). This nucleotide variation predicts the
substitution of the cytosine (TGC) at position 240 in the
resulting amino acid sequence by a nonsense codon (TGA;
C240X) (ﬁg. 1B). This nucleotide variation was not found
in 100 chromosomes from control individuals, which sug-
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Figure 3. Clinical phenotypes of patient IV.4, the affected daughter. A, Ocular appearance showing bilateral and symmetric micro-
phthalmia. B, Higher magniﬁcation of her left orbit, illustrating the sclerocornea. C and D, Axial and sagittal sections of cerebral MRI
(T1-weighted images) at the age of 3 years, showing absence of lens, symmetric eyeballs, and normal appearance of brain structures.
gests that it is not a common SNP. Sequence analysis con-
ﬁrmed that both parents carried this mutation in the het-
erozygous state, which supports the hypothesis that the
transmission of the phenotype is compatible with auto-
somal recessive inheritance (ﬁg. 1A and 1B). Thismutation
results in the truncation of the 80 C-terminal aa that rep-
resent more than one-quarter of the total protein length
of 319 aa. The functional consequences of premature ter-
mination codon (PTC) mutations are commonly expected
to be null alleles, because these mutant mRNA are likely
to be detected by RNA surveillance and to be degraded by
nonsense-mediated decay (NMD).25 This mechanism pre-
vents the accumulation of truncated proteins that could
interfere with the function of the normal protein or that
could have toxic effects in the cell, thereby protecting
many heterozygous carriers of genes with PTC mutations
from manifesting dominantly inherited disease pheno-
types. Here, both carrier parents had normal ocular ex-
amination, which supports the hypotheses that mRNA
containing C240X has most probably been subjected to
NMD and that the congenital aphakia in the children re-
sults from FOXE3 haploinsufﬁciency.
Elsewhere, two human FOXE3 missense mutations
were identiﬁed in the heterozygous state in two families
independently presenting anterior segment dysgenesis
(ASD) with cataract or Peters’ anomaly.23,24 Of these, one
was a single-nucleotide frameshift insertion, 15 bp up-
stream of the stop codon in FOXE3, that replaced the last
5 aa of the predicted protein with 116 novel residues.24 The
second missense mutation reported in FOXE3 gave rise to
a nonconservative amino acid substitution (Arg90Leu) lo-
cated in the DNA-binding domain, without impairing the
ﬁxation of FOXE3.23 These two FOXE3missensemutations
were found in the heterozygous state and caused a dom-
inantly inherited lens phenotype milder than that ob-
served in our family, which had a recessively inherited
CPA. The fact that currently reported FOXE3 mutations
result in variable ocular anterior segment phenotypes and
distinct inheritance patterns highlights the complexity of
this disease condition. Ocular ASD is a phenotypic and
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Figure 4. Histologic aspect of eyes from proband IV.1. A, Pho-
tograph representing section through the entire eye (hematoxylin-
eosin staining [HES]). Note the absence of lens, with a empty
cavity most probably corresponding to the vitreous (*), the aplasia
of the anterior chamber (arrow), the dysplastic retina, and the
presence of the optic nerve (magniﬁcation 4#). c p Cornea; on
p optic nerve; r p retina. B, Histological photograph of the
anterior segment of the eye, stained with anti–a-smooth muscular
actin antibody. The anterior chamber space, including iris and
ciliary body, is not formed, and the posterior face of the corneal
stroma is lined by a layer of muscular smooth cells, a ﬁbrocon-
nective tissue, and a continuous layer of pigmented cells (*). pe
p Pigmented epithelium. C, Abnormal folds of the retina with
rosette-like structures in which the retinal lamination is disturbed
(HES; magniﬁcation 20#).
genetically heterogeneous condition that has also been
associated with mutations in PAX6, FOXC1, PITX3, or
PITX2.15,16,20 All these genes have not been exhaustively
screened in the patients with FOXE3 mutations reported
by Semina et al.24 or Ormestad et al.23 It is, therefore, not
excluded that the presence of additional variants in genes
having related functions in the development of the an-
terior segment of the eye could likely inﬂuence the pen-
etrance and expressivity of ocular phenotypes observed in
patients with FOXE3. At the present time, the small num-
ber of patients reported with FOXE3 mutations limits
an accurate genotype-phenotype correlation, which will
await the complete understanding of the pathogenic
mechanism of FOXE3 mutations.
The involvement of FOXE3 in this family is interesting,
in different regards. First, it is a gene whose expression is
restricted to prelens and lenticular tissues, which provides
the opportunity to better deﬁne the direct role of the lens
on the formation of the diverse structures of the eye.21,22
In this family, the disease phenotype is perfectly restricted
to ocular tissues, as is expected for this gene. Similarly to
Foxe3/ mice, the brain structures of our patients have
not shown any malformations, although Foxe3 shows
transient expression in discrete regions of the developing
midbrain between E8.5 and E12.0 of mouse embryo-
genesis.21,22 Secondly, our data emphasize the role of
FOXE3 as essential for early developmental stages of the
lens—an unexpected ﬁnding—while the molecular cas-
cades that result in the formation of a lens are being
elucidated.6,7,26 In the mouse, two spontaneous Foxe3 mis-
sense mutations predicted to be null alleles cause the re-
cessive dysgenetic lens (dyl) mouse phenotype.21,22 The dyl
mice, which are viable and appear normal, have defects
in lens vesicle closure and separation, which implies that
Foxe3 is an essential regulator of this event. Finally, mice
deﬁcient in Foxe3 through targeted gene disruption show
lens abnormalities similar to those described for the dyl
mice.27 Despite these twomouse Foxe3models, themurine
lens phenotype remains milder than that observed in our
aphakic children carrying the C240X nonsense mutation
in the human gene counterpart. Usually, haploinsufﬁ-
ciency mutations in murine and in human orthologous
genes result in similar phenotypes, and a large number of
animal models have contributed to the understanding of
human diseases. However, interspecies differences exist,
and it is accepted that mice are often more tolerant of
haploinsufﬁciency for developmental genes than are hu-
mans.10 One possibility to explain these phenotypic dif-
ferences may be the existence in the mouse of an addi-
tional Foxe gene family member, which may be func-
tioning partly redundantly to Foxe3. Indeed, appreciable
differences have been noted elsewhere between ocular
phenotypes of certain human and murine forkhead or-
thologues, whose mechanisms have not been clariﬁed.28
Alternatively, the possibility remains that our FOXE3 non-
sense mutation does not result in total loss of function,
and we cannot formally exclude the possibility that this
mutation could result, in fact, in partial loss of function.
The human FOXE3 gene contains a single coding-exon
genomic structure, and some intronless genes have been
reported to be insensitive to NMD.25 Consequently, it re-
mains possible that PTC mutations in FOXE3 could escape
RNA surveillance and could produce truncated mutant
proteins. In this scenario, absence of lens in our patients
could result in the production of a truncated protein that
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Figure 5. Histologic and immunohistochemical analyses of eyes from proband IV.1. A, HES (left panel) and immunohistochemical
staining with anti–a-smooth muscular actin (right panel) of the posterior corneal stroma, showing absence of corneal endothelium and
Descemet’s membrane, vascularized corneal stroma (arrowhead), and the different abnormal tissues that adhered to the posterior face
of the cornea (magniﬁcation 10# and 20#, respectively). The arrow points to the site where corneal endothelium and Descemet’s
membrane normally take place in the cornea. cs p Corneal stroma; fvt p ﬁbrovascular tissue; pe p pigmented epithelium; smc p
smooth muscular cells. B, HES showing the pigmented epithelium that occasionally forms some folds resembling ciliary processes, with
higher magniﬁcation (20#) shown in the box. C, HES (panel a) and immunohistochemical staining with antivimentin (panel b), anti–
a-smooth actin (panel c), and anti-CK7 (panel d) antibodies of the pigmented ciliary epithelium. Only vimentin immunohistochemical
staining is positive (magniﬁcation 40#). D, Immunohistochemical staining with antidesmin antibody (magniﬁcation 40#). Only smooth
muscular cells lining the posterior face of the corneal stroma are positive. E and F, Immunohistochemical positive staining with anti-
HMB45 antibody in the choroid and in some cells (arrow) within the ectopic ﬁbromuscular tissue adherent to the cornea.
is still capable of binding DNA but is devoid of the 80 C-
terminal aa. FOXE3 is a transcription factor that acts by
switching on and off expression of other genes and that
must be correctly activated or repressed at the appropriate
time during lens development. However, the targets of
FOXE3 are not known, and it is not known whether
FOXE3 could act synergistically with other partner(s), as
Pax6 and Sox2 do, both of which form a co–DNA-binding
complex that regulates initiation of lens development.12
The C240X mutation lies outside the forkhead domain of
FOXE3, but it is included in a 26-aa motif (PEPPCCAAP-
DAAAAAFPPCAAAASPPLYS) that is highly conserved be-
tween mouse and human, which suggests that this motif
is, most probably, important for the normal function of
FOXE3 (ﬁg. 1C). We could conceive that these residues
might be essential, for example, to exert the transactiva-
tion effects of FOXE3 in its interactions with some uni-
dentiﬁed partners, even though DNA binding still oc-
curred. Thus, a full understanding of the potential role of
FOXE3 in early stages of lens development would require
the identiﬁcation of genes that may be directly controlled
by FOXE3 at this speciﬁc developmental stage and the
elucidation of the mechanisms by which FOXE3 exerts its
actions.
However, in the developing eye of the mouse, the onset
of Foxe3 expression begins very early in the presumptive
lens ectoderm, and its expression is ﬁrst detected as early
as E.8.75, a period when the Pax6 ectoderm enhancer be-
comes active and directs Pax6 expression in the surface
ectoderm (SE).7,22,29 During lens placode formation at
E.9.5, Foxe3 expression is upregulated in the SE, in con-
junction with transcription factors Six3, Sox2/Sox3, and
Prox1.8,11,12 Then, Foxe3 expression becomes conﬁned to
the lens vesicle as this structure detaches from the SE
(E10.5), a process that fails in both dyl and Foxe3/ mice.
Therefore, the temporal expression pattern of Foxe3highly
supports a possible role for Foxe3 in earlier stages of lens
development upstream of events such as lens vesicle sep-
aration or lens lineage proliferation. A unique demon-
stration in support of this hypothesis is the identiﬁcation
here—to our knowledge, for the ﬁrst time—of a nonsense
mutation in FOXE3 that cosegregates with familial CPA.
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Although identiﬁcations of human disease-causing genes
have been often guided by study of their murine ortho-
logues, the family in this article illustrates that the con-
verse approach might also provide a means of identifying
a novel phenotype that has not yet been revealed in mice.
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